90 related articles for article (PubMed ID: 24169325)
1. [Relationship between the expressions of indoleamine 2, 3-dioxygenase in hepatocellular carcinoma and clinicopathological parameters].
Lin L; Yang DH; Huang Y; Li XH; Zhang QL; Liu X; Liang JK; Zhong KB; He H
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2186-90. PubMed ID: 24169325
[TBL] [Abstract][Full Text] [Related]
2. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma.
Pan K; Wang H; Chen MS; Zhang HK; Weng DS; Zhou J; Huang W; Li JJ; Song HF; Xia JC
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1247-53. PubMed ID: 18438685
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
[TBL] [Abstract][Full Text] [Related]
5. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma.
Asghar K; Farooq A; Zulfiqar B; Rashid MU
World J Gastroenterol; 2017 Apr; 23(13):2286-2293. PubMed ID: 28428708
[TBL] [Abstract][Full Text] [Related]
7. Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma.
Ishio T; Goto S; Tahara K; Tone S; Kawano K; Kitano S
J Gastroenterol Hepatol; 2004 Mar; 19(3):319-26. PubMed ID: 14748880
[TBL] [Abstract][Full Text] [Related]
8. [Expression of special AT-rich sequence-binding protein 1 mRNA in hepatocellular carcinoma and its clinical significance].
Peng ZK; Yang DH; Li XH; Huang Y; Zhang GQ; Zhong KB; Bi MP; Li GH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1207-11. PubMed ID: 21764697
[TBL] [Abstract][Full Text] [Related]
9. [Association of cellular inhibitor of apoptosis protein-2 expression with clinical outcomes of hepatocellular carcinoma].
Bi M; Yang D; Li X; Zhong K; Liu Y; Li G; Liao X; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1020-5, 1030. PubMed ID: 22820591
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine-pyrrole 2,3-dioxygenase might be a prognostic biomarker for patients with renal cell carcinoma.
Yuan F; Liu Y; Fu X; Chen J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 37(7):649-55. PubMed ID: 22886215
[TBL] [Abstract][Full Text] [Related]
11. High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients.
Asghar K; Rana IA; Abubakar M; Hasham K; Tahseen M; Bilal S; Mehmood S; Farooq A; Siddique K; Loya A
Asian Pac J Cancer Prev; 2023 May; 24(5):1591-1600. PubMed ID: 37247278
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
13. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M
Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
[TBL] [Abstract][Full Text] [Related]
14. [Study of indoleamine 2,3-dioxygenase expression in patients of thyroid cancer].
Sakurai K; Fujisaki S; Nagashima S; Shibata M; Maeda T; Ueda Y; Hara Y; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1927-9. PubMed ID: 22202241
[TBL] [Abstract][Full Text] [Related]
15. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
[TBL] [Abstract][Full Text] [Related]
16. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
17. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma].
Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068
[TBL] [Abstract][Full Text] [Related]
19. Involvement of RhoA in progression of human hepatocellular carcinoma.
Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y
J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970
[TBL] [Abstract][Full Text] [Related]
20. [Expression and its clinicopathological features of tumor rejective antigen 1 in human tissues of hepatocellular carcinoma and liver cirrhosis].
Zhang H; Huang DF; Wei Q; Hua TY; Li F; Huang JF
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):661-5. PubMed ID: 20943076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
